World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
61830
World Ranking
4647
National Ranking
453

Vlado Perkovic publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Vlado Perkovic sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 463 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Vlado Perkovic D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Vlado Perkovic sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 114 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2016 - Fellow of the Australian Academy of Health and Medical Science

Overview

Vlado Perkovic is affiliated with the George Institute for Global Health in the United Kingdom. Their research primarily focuses on medicine, with significant contributions in subfields such as endocrinology, diabetes and metabolism, nephrology, surgery, cardiology and cardiovascular medicine, as well as hematology.

Perkovic's recent publications cover several topics related to kidney disease, diabetes, and cardiovascular health. Notable papers include:

  • "Chronic kidney disease" (2021) published in The Lancet
  • "Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis" (2021) published in The Lancet
  • "Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials" (2022) published in The Lancet
  • "Effects of Allopurinol on the Progression of Chronic Kidney Disease" (2020) published in New England Journal of Medicine
  • "Prevalence of chronic kidney disease in Asia: a systematic review and analysis" (2022) published in BMJ Global Health

Their work frequently addresses topics such as diabetes treatment and management, pancreatic function and diabetes, chronic kidney disease in relation to diabetes, diabetes management and research, renal diseases and glomerulopathies, dialysis and renal disease management, and erythropoietin and anemia treatment. These topics reflect a focused research agenda at the intersection of metabolic and renal health.

Perkovic has collaborated extensively with several researchers, with the most frequent co-authors including Hiddo J.L. Heerspink, Meg Jardine, Kenneth W. Mahaffey, Brendon L. Neuen, and Bruce Neal. Such collaborations indicate active involvement in large-scale clinical research and meta-analyses.

Their research is published prominently in venues specializing in nephrology and metabolic diseases. Key publication outlets include the Journal of the American Society of Nephrology, Kidney International Reports, Nephrology Dialysis Transplantation, Diabetes Obesity and Metabolism, and the Clinical Journal of the American Society of Nephrology.

In 2016, Vlado Perkovic was recognized as a Fellow of the Australian Academy of Health and Medical Science, highlighting established standing within the medical research community.

Best Publications

  • Canagliflozin and cardiovascular and renal events in type 2 diabetes

    Bruce Neal;Vlado Perkovic;Vlado Perkovic;Kenneth W. Mahaffey;Dick de Zeeuw

  • Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

    Vlado Perkovic;Vlado Perkovic;Meg J. Jardine;Meg J. Jardine;Bruce Neal;Bruce Neal;Bruce Neal;Severine Bompoint

  • Worldwide access to treatment for end-stage kidney disease: a systematic review.

    Thaminda Liyanage;Thaminda Liyanage;Toshiharu Ninomiya;Vivekanand Jha;Vivekanand Jha;Vivekanand Jha;Bruce Neal

  • Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.

    Min Jun;Celine Foote;Jicheng Lv;Jicheng Lv;Bruce Neal

  • Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

    Toshiharu Ninomiya;Vlado Perkovic;Bastiaan E de Galan;Bastiaan E de Galan;Sophia Zoungas

  • Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.

    Julio Rosenstock;Vlado Perkovic;Odd Erik Johansen;Mark E. Cooper

  • Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials.

    Fiona Turnbull;B Neal;T. Ninomiya

  • Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

    Adeera Levin;Marcello Tonelli;Joseph Bonventre;Josef Coresh

  • Blood Pressure Lowering in Type 2 Diabetes: A Systematic Review and Meta-analysis

    Connor A. Emdin;Kazem Rahimi;Bruce Neal;Thomas Callender

  • A Call to Action and a Lifecourse Strategy to Address the Global Burden of Raised Blood Pressure on Current and Future Generations: The Lancet Commission on Hypertension

    Michael H. Olsen;Michael H. Olsen;Sonia Y. Angell;Samira Asma;Pierre Boutouyrie

  • Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes

    Sophia Zoungas;John Chalmers;Bruce Neal;Laurent Billot

  • SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

    Brendon L Neuen;Tamara Young;Hiddo J L Heerspink;Hiddo J L Heerspink;Bruce Neal;Bruce Neal;Bruce Neal

  • Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis

    Xinfang Xie;Emily Atkins;Jicheng Lv;Jicheng Lv;Alexander Bennett

  • Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data

    Johan Sundström;Johan Sundström;Hisatomi Arima;Mark Woodward;Mark Woodward;Rod Jackson

  • Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus: A Systematic Review With Meta-analysis

    Rachel Huxley;Crystal Man Ying Lee;Federica Barzi;Leif Timmermeister

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    Kazem Rahimi;Zeinab Bidel;Milad Nazarzadeh;Emma Copland

  • Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

    Vlado Perkovic;Vlado Perkovic;Dick de Zeeuw;Kenneth W Mahaffey;Greg Fulcher

  • Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials

    Hiddo J Lambers Heerspink;Hiddo J Lambers Heerspink;Toshiharu Ninomiya;Sophia Zoungas;Sophia Zoungas;Dick de Zeeuw

  • Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis

    Jason H Y Wu;Celine Foote;Celine Foote;Juuso Blomster;Juuso Blomster;Tadashi Toyama

  • Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease

    Gavin J. Becker;David C. Wheeler;Dick De Zeeuw;Toshiro Fujita

Frequent Co-Authors

Bruce Neal
Bruce Neal George Institute for Global Health
Alan Cass
Alan Cass Charles Darwin University
Hiddo J.L. Heerspink
Hiddo J.L. Heerspink University of Groningen
Dick de Zeeuw
Dick de Zeeuw University of Groningen
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Mark Woodward
Mark Woodward Imperial College London
John Chalmers
John Chalmers University of New South Wales
Sophia Zoungas
Sophia Zoungas Monash University
Carmel M. Hawley
Carmel M. Hawley University of Queensland
Toshiharu Ninomiya
Toshiharu Ninomiya Kyushu University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a career in medicine can follow multiple paths. For students wanting a head start, the best online schools for high school students can introduce foundational healthcare subjects early on, making the college transition smoother.

Aspiring professionals who are not ready to commit fully to medical school have flexible alternatives. For example, a low cost medical coding and billing online program provides entry into healthcare administration and patient records management with minimal up-front investment.

Nursing remains one of the most in-demand careers in healthcare. Those interested in advancing their expertise can benefit from cheapest online np programs, which are ideal for gaining specialized skills without the financial strain of traditional routes.

At the same time, accessible options abound with cheap online nursing programs that open doors to rewarding careers in patient care. These online pathways make healthcare education more attainable, allowing students to learn at their own pace and budget while preparing for vital roles in the medical field.

Best Scientists Citing Vlado Perkovic

Trending Scientists

Recently Published Articles